Eversept Partners, LP Sc Pharmaceuticals Inc. Transaction History

Eversept Partners, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.17 - $9.41 $339,177 - $617,343	-65,605 Closed	0 $0
Q3 2020 Nov 08, 2023	SELL	$7.12 - $8.86 $1.29 Million - $1.61 Million	-181,814 Reduced 73.48%	65,605 $488,000
Q3 2020 Nov 13, 2020	SELL	$7.12 - $8.86 $1.29 Million - $1.61 Million	-181,814 Reduced 73.48%	65,605 $489,000
Q2 2020 Nov 08, 2023	BUY	$7.01 - $10.96 $806,150 - $1.26 Million	115,000 Added 86.85%	247,419 $1.82 Million
Q2 2020 Aug 13, 2020	BUY	$7.01 - $10.96 $806,150 - $1.26 Million	115,000 Added 86.85%	247,419 $1.82 Million
Q1 2020 Nov 08, 2023	SELL	$5.4 - $10.45 $913,771 - $1.77 Million	-169,217 Reduced 56.1%	132,419 $979,000
Q1 2020 May 13, 2020	SELL	$5.4 - $10.45 $913,771 - $1.77 Million	-169,217 Reduced 56.1%	132,419 $980,000
Q4 2019 Nov 08, 2023	BUY	$4.1 - $6.21 $328,000 - $496,800	80,000 Added 36.1%	301,636 $1.71 Million
Q4 2019 Feb 13, 2020	BUY	$4.1 - $6.21 $328,000 - $496,800	80,000 Added 36.1%	301,636 $1.71 Million
Q3 2019 Nov 08, 2023	BUY	$3.24 - $7.35 $153,378 - $347,941	47,339 Added 27.16%	221,636 $1.3 Million
Q3 2019 Nov 13, 2019	BUY	$3.24 - $7.35 $153,378 - $347,941	47,339 Added 27.16%	221,636 $1.3 Million
Q2 2019 Nov 08, 2023	BUY	$2.48 - $3.76 $432,256 - $655,356	174,297 New	174,297 $556,000
Q2 2019 Aug 13, 2019	BUY	$2.48 - $3.76 $432,256 - $655,356	174,297 New	174,297 $556,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $97M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.